Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Steroids|February 19, 2018
Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinomaVasiliki Pelekanou, Eleftheria Anastasiou, Efstathia Bakogeorgou, et al.
The Journal of Pathology|November 10, 2011
Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancerFiona Furlong, Patricia Fitzpatrick, Sharon O'Toole, et al.
BJUI Compass|January 29, 2025
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancerAgnieszka Krzyzanowska, Debra F Higgins, Stephen Barron, et al.
European Urology Focus|April 27, 2023
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate CancerAgnieszka Krzyzanowska, Stephen Barron, Debra F Higgins, et al.
Histopathology|October 22, 2013
Investigation of molecular alterations of AKT-3 in triple-negative breast cancerGillian O'Hurley, Etáin Daly, Anthony O'Grady, et al.
Cancer Biology & Therapy|December 25, 2008
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkersRuth Foley, Laure Marignol, Arun Z Thomas, et al.
International Journal of Cancer|August 24, 2012
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancerAntoinette S Perry, Gillian O'Hurley, Omer A Raheem, et al.
Cancer Research|March 3, 2011
The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancerNiamh E Buckley, Susan J Conlon, Karin Jirstrom, et al.
BMJ Oncology|January 31, 2025
Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with 'persister' cell profiles fail to benefit from adjuvant chemotherapySanghee Cho, Elizabeth McDonough, John Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalizationEmma M Gallagher, Deirdre M O'Shea, Patricia Fitzpatrick, et al.
Pageof 6